Lv1
14 积分 2023-03-06 加入
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
15小时前
已完结
Antibody Drug Conjugates for Cancer Therapy
12天前
已完结
Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929
29天前
已完结
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
1个月前
已完结
Carboplatin dosage: prospective evaluation of a simple formula based on renal function
2个月前
已完结
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China
2个月前
已完结
Atypical Central Retinal Vein Occlusion in an Older Man With Multiple Myeloma: A Case Report
4个月前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
4个月前
已完结
Biomarkers for Antibody–Drug Conjugates in Solid Tumors
4个月前
已完结
Unveiling the intra-tumor fate of trastuzumab deruxtecan in a xenograft model to support its mechanism of action
4个月前
已完结
皖公网安备34019202002308
